Dj. Loes et al., Globoid cell leukodystrophy: Distinguishing early-onset from late-onset disease using a brain MR imaging scoring method, AM J NEUROR, 20(2), 1999, pp. 316-323
Citations number
23
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
BACKGROUND AND PURPOSE: Our purpose aas to determine the characteristic MR
features of early-onset (before age 2 years) versus Irate-onset (after age
2 years) globoid cell leukodystrophy (GLD);
METHODS: Thirty-four brain MR images in 22 patients with GLD were reviewed.
A severity score (0 to 32), based on a point system derived from the locat
ion and extent of disease and the presence of focal and/or global atrophy,
was calculated for each examination.
RESULTS: Of the 22 patients, three were asymptomatic and 19 were symptomati
c. Ten patients had early-onset disease, whereas nine had late-onset diseas
e. MR changes of all patients showed abnormalities. In the early-onset grou
p (n = 10; mean maximum MR score, 8.1; range, 3-18), 90% had pyramidal trac
t involvement, 80% had cerebellar white matter involvement, 70% had deep gr
ay matter involvement, and 40% had posterior corpus callosal involvement, 5
0% had parietooccipital white matter involvement, and 40% had cerebral atro
phy. Serial MR imaging in four of these patients revealed progressive disea
se. In the late-onset group (n = 9; mean maximum MR score, 5.6; range, 4-10
), 100% had pyramidal tract involvement, 100% had parietooccipital white ma
tter involvement, 89% had posterior corpus callosal involvement, and none h
ad cerebellar white matter involvement, deep gray matter involvement, or ce
rebral atrophy. Serial MR imaging in one patient with late-onset GLD did no
t reveal any change, a spectrum of findings was observed in the three patie
nts who were asymptomatic.
CONCLUSION: Cerebellar white matter and deep gray matter involvement are pr
esent only in early-onset GLD. Pyramidal tract involvement is a characteris
tic finding in both early- and late-onset GLD. This scoring method for brai
n MR observations will assist in the objective assessment of the impact of
hematopoietic stem cell transplantation in patients with GLD.